WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Gap Up – Time to Buy?

Posted by on Nov 10th, 2026

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) shares gapped up prior to trading on Tuesday. The stock had previously closed at $12.51, but opened at $12.9399. WuXi Biologics (Cayman) shares last traded at $12.52, with a volume of 46,436 shares traded.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One research analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Get Our Latest Stock Report on WXXWY

WuXi Biologics (Cayman) Stock Down 0.0%

The stock has a fifty day moving average of $12.77 and a 200-day moving average of $10.26.

About WuXi Biologics (Cayman)

(Get Free Report)

WuXi Biologics (Cayman) Inc. is a contract research, development and manufacturing organization focused on biologic medicines. Founded in 2010, the company provides services to biotechnology and pharmaceutical companies developing treatments for patients worldwide. Its services span the biologics development process, including discovery, cell-line and process development, analytical testing, and clinical and commercial manufacturing. The company works with products such as monoclonal and multispecific antibodies, recombinant proteins, and antibody-drug conjugates.

Further Reading

Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.